Our Team

Fulton Mark

Mark Fulton, PhD

Mark Fulton manages and supports a strategic research alliance focused on the development of technologies to help address lung diseases.  Prior to joining Mass General Brigham, he was a consultant working to help develop pharmaceutical strategy and support clinical decision-making. He earned his Ph.D. from Vanderbilt University in the lab of Prof. Craig Lindsley, working to develop small molecules to probe the function of a unique receptor in the brain to better understand its function and potential as a drug target. He then went on to complete a postdoc at Harvard University with Prof. Matt Shair, working across several projects focused on developing small molecules for the treatment of several cancers.